Cognitive Behavioral Therapy (REBT/CBT) Evaluation for Dysthymia in the Practice of Clinical Social Work at Primary Care
Evaluation of the Effectiveness of Rational Emotive Behavioral Therapy (REBT/CBT) as an Intervention Tool in Clinical Social Work Consultation to Primary Care.
1 other identifier
interventional
129
1 country
1
Brief Summary
Introduction: Minor psychiatric disorders are important in primary care, because of its high prevalence and consumption of healthcare resources generated. Objective: Evaluate the effectiveness of rational emotive behavioral therapy (REBT), as an instrument of social work intervention to enhance changes in the parameters of quality of life, medical consultations and drug use in patients with dysthymia. Design: Multicenter, prospective, not randomized clinical trial, with intervention and control group simultaneously in urban primary care settings and 1 year of follow up. Participants: Out-patients seen in two Primary Care centers diagnosed with dysthymia according to DSM-IV classification of American Psychiatric Association. Intervention: Subjects receive up to 8 biweekly individual sessions of thirty minutes of REBT administered by the Social Worker. Variables: Demographic data, educational level, coexistence, comorbidity, quality of life assessment, severity of depression, number of visits to the General Practitioner (GP) and drug consumption: sedatives / antidepressants. Expected Results: The expected results of the intervention, estimated from previous data, are:
- A decrease in attendance at medical visits per year
- An improvement in perceived quality of life, measured as values of the Quality of Life (QOL) questionnaire (Baker \& Intagliata)
- An improvement in severity of depression, measured according to the Beck Depression Inventory.
- A reduction of treatment with psychotropic drugs (sedatives and antidepressants). Potential impact expected: The investigators hope that rational emotive theory is an effective intervention method for handling minor psychiatric disorders in clinical social work.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable depression
Started Oct 2009
Longer than P75 for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedFirst Submitted
Initial submission to the registry
April 9, 2014
CompletedFirst Posted
Study publicly available on registry
April 14, 2014
CompletedResults Posted
Study results publicly available
September 24, 2024
CompletedSeptember 24, 2024
March 1, 2014
3.5 years
April 9, 2014
January 26, 2022
September 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change From Baseline in Severity of Depression, Measured According to the Beck Depression Inventory, at 4 and 12 Months.
The Beck Depression Inventory (BDI) consisted of twenty-one questions about how the subject has been feeling in the last week. Each question has a set of at least four possible answer choices, ranging in intensity. When the test is scored, a value of 0 to 3 is assigned for each answer and then the total score is compared to a key to determine the depression's severity. The standard cut-offs are as follows: * 0-9: indicates minimal depression * 10-18: indicates mild depression * 19-29: indicates moderate depression * 30-63: indicates severe depression. Higher total scores indicate more severe depressive symptoms.
Baseline, month 4, month 12.
Secondary Outcomes (1)
Change From Baseline in Perceived Quality of Life, Measured as Values of Satisfaction With Life Domains Scale (SLDS) at 4 and 12 Months
Baseline, month 4, month 12.
Other Outcomes (2)
Average Number of Visits of Attendance at Medical Visits in Previous Year and 1 Year of Follow up Date.
Baseline, 1 year
Percentage of People in the Group Who Stop Taking or Reduce the Dose of Psychotropic Drugs at 12 Months
Baseline, months 12
Study Arms (2)
Rational-Emotive-Behavioral Therapy
EXPERIMENTALA social worker held eight 30 minutes sessions fortnightly of Rational-Emotive-Behavioral Therapy. First session is informative about the type of treatment to be performed. The next sessions work events, thoughts and feelings with the goal of changing the dysfunctional thoughts by other more rational ones, measured by scales.
Control Group
ACTIVE COMPARATORThe control group (GC) will take the usual medical care for dysthymia, according with up-dated guidelines.
Interventions
A social worker held eight 30 minutes sessions fortnightly. First session is informative about the type of treatment to be performed. The next sessions work events, thoughts and feelings with the goal of changing the dysfunctional thoughts by other more rational ones, measured by scales.
In the control group the dysthymia is treated as usual with the conventional treatment.
Eligibility Criteria
You may qualify if:
- Clinical diagnosis fo dysthymia
- Aged 14 or older
You may not qualify if:
- Impaired cognitive ability
- Illiteracy
- Refuses treatment
- Severe psychiatric disorders
- Participation in psychoeducational groups or other similar therapies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Catalan Health Institute. ABS Sant Andreu 9D
Barcelona, 08030, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Principal Investigator: Carme Rovira Aler
- Organization
- Institut CatalĂ de la Salut
Study Officials
- PRINCIPAL INVESTIGATOR
Carme Rovira Aler, LCSW
Catalan Institute of Health
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 9, 2014
First Posted
April 14, 2014
Study Start
October 1, 2009
Primary Completion
April 1, 2013
Study Completion
June 1, 2013
Last Updated
September 24, 2024
Results First Posted
September 24, 2024
Record last verified: 2014-03